4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-129143
Chief Executive Officer sold 26,198 shares at $50.07 ($1,311,826)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-25 | Sale : show line 1 in the form 10b5-1 | −26,198 | $50.07 | $1,311,826 | 2,918,326 | I |
| Open-market sales · 26,198 sh · avg $50.07 · $1,311,826 | ||||||
Loading xslF345X06/ownership.xml…